Monday to Sunday: 24/7 Hours Service
Published : 24 February, 2026
The coverage includes a comprehensive pre-Budget 2026 media narrative highlighting expectations from the Union Budget with a strong focus on strengthening India’s oncology ecosystem. It features perspectives from RGCIRC through its CEO, Mr. D.S. Negi (IAS Retd.), emphasizing that while cancer drug funding remains important, effectively addressing the rising cancer burden requires parallel investment in advanced medical equipment, oncology infrastructure, preventive healthcare, and equitable access to quality treatment, particularly for underserved populations. In his remarks, he underscores that medicines alone cannot deliver optimal outcomes—sustainable cancer care demands equal prioritisation of diagnostic and treatment machinery, viewing healthcare hardware not as a luxury but as a critical public health enabler for long-term system resilience and improved patient survival.
